Jansen I, Olesen J, Edvinsson L
Department of Experimental Research, University of Lund, Malmö General Hospital, Sweden.
Acta Physiol Scand. 1993 Feb;147(2):141-50. doi: 10.1111/j.1748-1716.1993.tb09483.x.
We have studied the regional distribution of 5-hydroxytryptamine (5-HT) receptor subtypes in fresh circular segments of human cerebral, middle meningeal, and temporal arteries. Vasomotor responses induced by a series of 5-HT agonists and antagonists with some degree of selectivity were studied by using a sensitive in vitro system. Nine 5-HT agonists were examined for contractile effects on the arteries. In cerebral and meningeal arteries 5-carboxamidotryptamine (5-CT) was more potent than 5-HT. The opposite order of potency (5-HT-5-CT) was found in temporal arteries. In the cerebral arteries 5-methoxytryptamine (5-MeOHT) was more potent than sumatriptan while sumatriptan was more potent than 5-MeOHT in meningeal and temporal arteries. The 5-HT1 receptor antagonist, methiothepin, competitively antagonized 5-CT-induced contractions in cerebral arteries, with a pA2 value of 9.05. 5-HT-induced contractions were competitively antagonized by ketanserin (5-HT2) in the temporal arteries pA2 value of 9.06). Methiothepin and ketanserin had non-competitive antagonistic effects in the middle meningeal arteries. The 5-HT3 selective antagonist ondansetron did not cause any shift of the contractions induced by 2-methyl-5-HT in the temporal, cerebral and middle meningeal arteries. These results suggest that the cerebral arteries mainly contain 5-HT1D or 5-HT1-like receptors, and the temporal artery 5-HT2 receptors; the data further indicate the presence of both receptor subtypes in the middle meningeal artery.
我们研究了5-羟色胺(5-HT)受体亚型在人脑动脉、脑膜中动脉和颞动脉新鲜环状节段中的区域分布。通过使用灵敏的体外系统,研究了一系列具有一定选择性的5-HT激动剂和拮抗剂诱导的血管舒缩反应。检测了9种5-HT激动剂对动脉的收缩作用。在脑动脉和脑膜动脉中,5-羧基酰胺色胺(5-CT)比5-HT更有效。在颞动脉中发现了相反的效价顺序(5-HT>5-CT)。在脑动脉中,5-甲氧基色胺(5-MeOHT)比舒马曲坦更有效,而在脑膜动脉和颞动脉中舒马曲坦比5-MeOHT更有效。5-HT1受体拮抗剂美噻吨竞争性拮抗5-CT诱导的脑动脉收缩,pA2值为9.05。在颞动脉中,5-HT诱导的收缩被酮色林(5-HT2)竞争性拮抗(pA2值为9.06)。美噻吨和酮色林在脑膜中动脉中具有非竞争性拮抗作用。5-HT3选择性拮抗剂昂丹司琼并未引起2-甲基-5-HT在颞动脉、脑动脉和脑膜中动脉诱导的收缩发生任何偏移。这些结果表明,脑动脉主要含有5-HT1D或5-HT1样受体,颞动脉含有5-HT2受体;数据进一步表明脑膜中动脉同时存在这两种受体亚型。